Media

With strong backgrounds in journalism, our team knows how to position your story for the outlets that matter most to you. We emphasize proactive outreach to reporters; we don’t wait for milestone news to pitch.

Meida

This isn’t our target list. It’s our training ground.

More than 50 years combined journalism experience to shape strategies, open doors and get results.

Featuring Morphic Therapeutic
October 9, 2020
Featuring Generation Bio
October 5, 2020
Feauting Generation Bio
October 2, 2020
Featuring CureVac
September 28, 2020
Featuring Rome Therapeutics
September 28, 2020
Featuring Schrödinger
September 11, 2020
Featuring Casma Therapeutics
September 10, 2020
Featuring Nimbus Therapeutics, AVROBIO Inc., Rome Therapeutics, and Schrödinger, Inc.
August 17, 2020
Featuring Seres Therapeutics
August 10, 2020
Featuring Verve Therapeutics
June 18, 2020
Featuring Verve Therapeutics, Triplet Therapeutics, and Tango Therapeutics
June 16, 2020
Featuring Verve Therapeutics
June 30, 2020
Featuring Seres Therapeutics
April 17, 2020
Featuring Leslie Meltzer, Orchard Therapeutics and Sadik Kassim, Vor BioPharma
April 6, 2020

“When one of your close friends or family members is touched by a rare disease, the disease is not rare anymore,” said Fred Chereau, CEO of LogicBio Therapeutics Inc.

The Boston Globe
Featuring LogicBio Therapeutics, AVROBIO, Dyne Therapeutics and Orchard Therapeutics
February 28, 2020
Featuring Korro Bio
February 4, 2020
Featuring PureTech Health
February 17, 2020
Featuring Compass Therapeutics
December 11, 2019
Featuring PureTech Health
July 30, 2019
Featuring Tango Therapeutics
July 30, 2018
Featuring Surface Oncology
May 9, 2019
Featuring Cedilla Therapeutics
March 6, 2019
Featuring Molecular Partners
May 16, 2019
Featuring Neon Therapeutics
October 10, 2019
Featuring Sigilon Therapeutics
July 15, 2019
Featuring Verve Therapeutics
May 19, 2019
Featuring Morphic Therapeutic
February 21, 2019
Featuring Neon Therapeutics, Cedilla Therapeutics and Tango Therapeutics
October 11, 2018
Featuring Spark Therapeutics
October 19, 2017